Confirmatory Study to Evaluate the Immunogenicity of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP Vaccine, BK1301) as a Booster in Adolescents
Phase of Trial: Phase III
Latest Information Update: 23 Nov 2016
At a glance
- Drugs BK 1301 (Primary) ; Diphtheria-tetanus vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics; Registrational
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 15 Oct 2014 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record.
- 12 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 30 Apr 2014 New trial record